While the proteomic studies clearly associate MP-G3BP overexpression with SLE and deep venous thrombosis, we anticipate that the future potential of G3BP and the other MP candidate biomarkers may be even far greater in cancer and chronic viral diseases. Here, G3BP1 is linked to Venous thrombosis.